Literature DB >> 8836608

Giant cell tumor of the occipital bone in a case of von Recklinghausen neurofibromatosis.

H Opitz1, D Petersen, E Heiss, F Duffner, R Meyermann.   

Abstract

Von Recklinghausen neurofibromatosis (NF1) is the most common hereditary syndrome predisposing to neoplasia. The most common symptomatic manifestation of NF1 is the plexiform neurofibroma. We describe the case of a patient with classical von Recklinghausen neurofibromatosis presenting with a giant cell tumor (GCT) of the occipital bone infiltrating a surrounding plexiform neurofibroma.

Entities:  

Mesh:

Year:  1996        PMID: 8836608

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  4 in total

1.  Giant cell tumor of the occipital bone: A case report and review of the literature.

Authors:  Gonca Hanedan Uslu; Emine Canyilmaz; Adnan Yöney; Sevdegül Aydin; Asli Sahbaz; Ahmet Sari
Journal:  Oncol Lett       Date:  2014-04-25       Impact factor: 2.967

2.  Surgical management of giant cell tumor invading the occipital bone: A case report and literature review.

Authors:  Jhon E Bocanegra-Becerra; Marco Gonzales-Portillo Showing; Luis A Huamán Tanta
Journal:  Surg Neurol Int       Date:  2022-08-12

3.  A Unique Case of Aggressive Central Giant Cell Granuloma in a 10-Year-Old Boy With 16p13.11 Microdeletion Syndrome.

Authors:  Betty J Shum; Mimi S Kim; Katelyn Kondra; Jeffrey A Hammoudeh; Charles Strom; Anna Ryabets-Lienhard
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

4.  Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome.

Authors:  Thomas E Neumann; Judith Allanson; Ines Kavamura; Bronwyn Kerr; Giovanni Neri; Jacqueline Noonan; Viviana Cordeddu; Kate Gibson; Andreas Tzschach; Gabriele Krüger; Maria Hoeltzenbein; Timm O Goecke; Hans Gerd Kehl; Beate Albrecht; Klaudiusz Luczak; Maria M Sasiadek; Luciana Musante; Rohan Laurie; Hartmut Peters; Marco Tartaglia; Martin Zenker; Vera Kalscheuer
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.